391 related articles for article (PubMed ID: 16730694)
1. Importance of acyl-coenzyme A:cholesterol acyltransferase 1/2 dual inhibition for anti-atherosclerotic potency of pactimibe.
Kitayama K; Tanimoto T; Koga T; Terasaka N; Fujioka T; Inaba T
Eur J Pharmacol; 2006 Jul; 540(1-3):121-30. PubMed ID: 16730694
[TBL] [Abstract][Full Text] [Related]
2. Multiple mechanisms of hypocholesterolemic action of pactimibe, a novel acyl-coenzyme A:cholesterol acyltransferase inhibitor.
Kitayama K; Koga T; Inaba T; Fujioka T
Eur J Pharmacol; 2006 Aug; 543(1-3):123-32. PubMed ID: 16814766
[TBL] [Abstract][Full Text] [Related]
3. Pactimibe stabilizes atherosclerotic plaque through macrophage acyl-CoA:cholesterol acyltransferase inhibition in WHHL rabbits.
Kitayama K; Koga T; Maeda N; Inaba T; Fujioka T
Eur J Pharmacol; 2006 Jun; 539(1-2):81-8. PubMed ID: 16690054
[TBL] [Abstract][Full Text] [Related]
4. Hypolipidemic and antioxidant activity of the novel acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor KY-455 in rabbits and hamsters.
Nakamura S; Kamiya S; Shirahase H; Kanda M; Yoshimi A; Tarumi T; Kurahashi K
Arzneimittelforschung; 2004; 54(2):102-8. PubMed ID: 15038459
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological profile of SMP-797, a novel acyl-coenzyme a: cholesterol acyltransferase inhibitor with inducible effect on the expression of low-density lipoprotein receptor.
Ioriya K; Kino K; Horisawa S; Nishimura T; Muraoka M; Noguchi T; Ohashi N
J Cardiovasc Pharmacol; 2006 Feb; 47(2):322-9. PubMed ID: 16495773
[TBL] [Abstract][Full Text] [Related]
6. Discovery and combinatorial synthesis of fungal metabolites beauveriolides, novel antiatherosclerotic agents.
Tomoda H; Doi T
Acc Chem Res; 2008 Jan; 41(1):32-9. PubMed ID: 17803269
[TBL] [Abstract][Full Text] [Related]
7. Divergent pharmacologic activities of PD 132301-2 and CL 277,082, urea inhibitors of acyl-CoA:cholesterol acyltransferase.
Krause BR; Black A; Bousley R; Essenburg A; Cornicelli J; Holmes A; Homan R; Kieft K; Sekerke C; Shaw-Hes MK
J Pharmacol Exp Ther; 1993 Nov; 267(2):734-43. PubMed ID: 8246149
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of human ACAT1 gene expression to promote the macrophage-derived foam cell formation by dexamethasone.
Yang L; Yang JB; Chen J; Yu GY; Zhou P; Lei L; Wang ZZ; Cy Chang C; Yang XY; Chang TY; Li BL
Cell Res; 2004 Aug; 14(4):315-23. PubMed ID: 15353128
[TBL] [Abstract][Full Text] [Related]
9. ACAT inhibitor pactimibe sulfate (CS-505) reduces and stabilizes atherosclerotic lesions by cholesterol-lowering and direct effects in apolipoprotein E-deficient mice.
Terasaka N; Miyazaki A; Kasanuki N; Ito K; Ubukata N; Koieyama T; Kitayama K; Tanimoto T; Maeda N; Inaba T
Atherosclerosis; 2007 Feb; 190(2):239-47. PubMed ID: 16626720
[TBL] [Abstract][Full Text] [Related]
10. Effect of VULM 1457, an ACAT inhibitor, on serum lipid levels and on real time red blood cell flow in diabetic and non-diabetic hamsters fed high cholesterol-lipid diet.
Vojtassáková E; Syneková M; Tazká D; Mátyás S; Hózová R; Sadlonová I; Svec P
Gen Physiol Biophys; 2007 Dec; 26(4):254-9. PubMed ID: 18281742
[TBL] [Abstract][Full Text] [Related]
11. Glibenclamide acts as an inhibitor of acyl-CoA:cholesterol acyltransferase enzyme.
Ohgami N; Kuniyasu A; Furukawa K; Miyazaki A; Hakamata H; Horiuchi S; Nakayama H
Biochem Biophys Res Commun; 2000 Oct; 277(2):417-22. PubMed ID: 11032738
[TBL] [Abstract][Full Text] [Related]
12. Accumulation of oleate-rich cholesteryl esters by acetyl-LDL in macrophages in the presence of an acyl-CoA: cholesterol acyltransferase inhibitor (Sandoz 58-035).
Shimasaki O; Mineo C; Mowri H; Ohkuma S; Takano T
Biochem Int; 1990; 20(2):389-96. PubMed ID: 2317217
[TBL] [Abstract][Full Text] [Related]
13. N-[2-[N'-pentyl-(6,6-dimethyl-2,4-heptadiynyl)amino]ethyl]- (2-methyl-1-naphthylthio)acetamide (FY-087). A new acyl coenzyme a:cholesterol acyltransferase (ACAT) inhibitor of diet-induced atherosclerosis formation in mice.
Nagata Y; Yonemoto M; Iwasawa Y; Shimizu-Nagumo A; Hattori H; Sawazaki Y; Kamei T
Biochem Pharmacol; 1995 Mar; 49(5):643-51. PubMed ID: 7887979
[TBL] [Abstract][Full Text] [Related]
14. A selective ACAT-1 inhibitor, K-604, suppresses fatty streak lesions in fat-fed hamsters without affecting plasma cholesterol levels.
Ikenoya M; Yoshinaka Y; Kobayashi H; Kawamine K; Shibuya K; Sato F; Sawanobori K; Watanabe T; Miyazaki A
Atherosclerosis; 2007 Apr; 191(2):290-7. PubMed ID: 16820149
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of acyl-CoA:cholesterol O-acyltransferase. synthesis and pharmacological activity of (+/-)-2-dodecyl-alpha-phenyl-N-(2,4,6-trimethoxyphenyl)-2H-tetrazole-5- acetamide and structurally related tetrazole amide derivatives.
O'Brien PM; Sliskovic DR; Picard JA; Lee HT; Purchase CF; Roth BD; White AD; Anderson M; Mueller SB; Bocan T; Bousley R; Hamelehle KL; Homan R; Lee P; Krause BR; Reindel JF; Stanfield RL; Turluck D
J Med Chem; 1996 Jun; 39(12):2354-66. PubMed ID: 8691430
[TBL] [Abstract][Full Text] [Related]
16. Acyl-coenzyme A:cholesterol acyltransferase inhibitors for controlling hypercholesterolemia and atherosclerosis.
Miyazaki A; Sakai M; Sakamoto Y; Horiuchi S
Curr Opin Investig Drugs; 2003 Sep; 4(9):1095-9. PubMed ID: 14582454
[TBL] [Abstract][Full Text] [Related]
17. Anti-atherogenic effect of citrus flavonoids, naringin and naringenin, associated with hepatic ACAT and aortic VCAM-1 and MCP-1 in high cholesterol-fed rabbits.
Lee CH; Jeong TS; Choi YK; Hyun BH; Oh GT; Kim EH; Kim JR; Han JI; Bok SH
Biochem Biophys Res Commun; 2001 Jun; 284(3):681-8. PubMed ID: 11396955
[TBL] [Abstract][Full Text] [Related]
18. The ACAT inhibitor, CI-1011 is effective in the prevention and regression of aortic fatty streak area in hamsters.
Nicolosi RJ; Wilson TA; Krause BR
Atherosclerosis; 1998 Mar; 137(1):77-85. PubMed ID: 9568739
[TBL] [Abstract][Full Text] [Related]
19. Selectivity of pyripyropene derivatives in inhibition toward acyl-CoA:cholesterol acyltransferase 2 isozyme.
Ohshiro T; Ohte S; Matsuda D; Ohtawa M; Nagamitsu T; Sunazuka T; Harigaya Y; Rudel LL; Omura S; Tomoda H
J Antibiot (Tokyo); 2008 Aug; 61(8):503-8. PubMed ID: 18997389
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of cholesterol release from rabbit foam cells by the action of a new inhibitor for acyl CoA:cholesterol acyltransferase (ACAT), HL-004.
Ishii I; Yokoyama N; Yanagimachi M; Ashikawa N; Hata M; Murakami S; Asami Y; Morisaki N; Saito Y; Ohmori S; Kitada M
J Pharmacol Exp Ther; 1998 Oct; 287(1):115-21. PubMed ID: 9765329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
